
From Bioassay Method Development to Commercial Testing at Pandemic Speed: the Story of AZD1222 (ChAdOx1 nCoV-19)

Speaker Presentation Umlauf Scott AstraZeneca 2022
From Bioassay Method Development to Commercial Testing at Pandemic Speed: the Story of AZD1222 (ChAdOx1 nCoV-19)